skip to Cookie NoticeSkip to contents

Your health and safety remain our top priority: Learn about our Safe Care Commitment | Use our Prescreen app before arrival for faster entry | Read the COVID-19 Vaccine FAQs

Header Skipped.

Kidney Disease Clinical Trials

Abatacept in Treatment Resistant Nephrotic Syndrome

BWH is now enrolling patients with Nephrotic Syndrome in this clinical trial. Call the Kidney-NExT Clinic at 617-732-6383 to enroll.

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children Over the Age of 6 With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD). Read more about the study.